Terry Hassold, Center for Reproductive Biology, Washington State University, USA
Susan Fisher, Department of Cell & Tissue Biology, University of California, San Francisco, USA
Thomas D’Hooghe, Universitair Fertiliteitscentrum, UZ Leuven, Holland
The Gen-Val Consortium
The Gen-Val Project is a biotechnological consortium made up of four business organisations which combine scientific-technological capacities such as sequencing (Lifesequencing, S.L.), bioinformatics (Biotech Vana, S.L. and Celeromics, S.L.) and genetic diagnoses (Igenomix, S.L. – which is included in the group of researchers at IVI (the Valencian Infertility Institute). This consortium aims to provide the health sector with a permanent advanced genetic diagnosis and prognosis service that is capable of diagnosing diseases or metabolopathies of a hereditary origin with a view to being able to research into more palliative and personalised treatments of these illnesses.
Igenomix is in the media
Igenomix is not affiliated with any news outlet or publication identified above. News coverage does not constitute an endorsement of Igenomix or its products.
IGENOMIX is a company that provides advanced services in reproductive genetics.
"Igenomix India do not perform pre-natal sex determination and disclosure of sex (boy or girl before birth) of fetus. It is prohibited and punishable under PC & PNDT Act."
In accordance with UK Data Protection Act 1998, we hereby inform the user that his/her personal data will be retained at Igenomix US Ltd only for the purposes of performing the requested genetic services. In addition, the user’s contact details may be subsequently used to send out information about our products and services which could be of a particular interest.
Data holders consent to the treatment of the data provided, guaranteeing and protecting the freedoms and rights marked by current legislation.
The owners of the data consent to the processing of the data provided, thereby guaranteeing and protecting the freedoms and rights defined in the legislation in force.
The owner of the data is entitled to exercise the rights of access, rectification, cancellation and objection by sending a written communication that includes a proof of ID addressed to Igenomix UK, Ltd at the following address: Surrey Technology Centre, 40 Occam Road Guildford, Surrey, GU2 7YG UK or by sending an email to email@example.com.
This company guarantees that adequate measures will be adopted to ensure the confidential handling of this data.